Bright Pharmaceuticals SE: Accounting for a Business Combination under IFRS 3

D. Detzen, S. Hoffmann, H. Zulch

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

This instructional resource familiarizes students with the accounting for business combinations under IFRS 3 and illustrates the uncertainty and professional judgment involved in asset valuation and consolidation. First, students need to assess the quality of information generated under IFRS 3 and fair value accounting. Second, they are asked to account for a business combination by identifying possible input parameters to measure several intangible assets and a contingent liability. Based on their valuation results, they compute the amount of goodwill recognized on the acquisition and assess the effects of their parameter choices on the values of different assets and liabilities. As an optional third task, the case asks students to consolidate the financial statements and evaluate the impact of the acquisition on the financial position of the acquirer. © 2013 Copyright Taylor and Francis Group, LLC.
Original languageEnglish
Pages (from-to)282-294
JournalAccounting Education: An International Journal
Volume22
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

pharmaceutical
assets
liability
student
consolidation
Values
uncertainty
resources
International Financial Reporting Standards
Business combinations
Pharmaceuticals
Contingent liabilities
Asset valuation
Intangible assets
Quality of information
Consolidation
Assets
Financial statements
Professional judgment
Resources

Cite this

@article{04f8228c03ec4f66b597fd360fdf7720,
title = "Bright Pharmaceuticals SE: Accounting for a Business Combination under IFRS 3",
abstract = "This instructional resource familiarizes students with the accounting for business combinations under IFRS 3 and illustrates the uncertainty and professional judgment involved in asset valuation and consolidation. First, students need to assess the quality of information generated under IFRS 3 and fair value accounting. Second, they are asked to account for a business combination by identifying possible input parameters to measure several intangible assets and a contingent liability. Based on their valuation results, they compute the amount of goodwill recognized on the acquisition and assess the effects of their parameter choices on the values of different assets and liabilities. As an optional third task, the case asks students to consolidate the financial statements and evaluate the impact of the acquisition on the financial position of the acquirer. {\circledC} 2013 Copyright Taylor and Francis Group, LLC.",
author = "D. Detzen and S. Hoffmann and H. Zulch",
year = "2013",
doi = "10.1080/09639284.2013.802425",
language = "English",
volume = "22",
pages = "282--294",
journal = "Accounting Education: An International Journal",
issn = "0963-9284",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

Bright Pharmaceuticals SE: Accounting for a Business Combination under IFRS 3. / Detzen, D.; Hoffmann, S.; Zulch, H.

In: Accounting Education: An International Journal, Vol. 22, No. 3, 2013, p. 282-294.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - Bright Pharmaceuticals SE: Accounting for a Business Combination under IFRS 3

AU - Detzen, D.

AU - Hoffmann, S.

AU - Zulch, H.

PY - 2013

Y1 - 2013

N2 - This instructional resource familiarizes students with the accounting for business combinations under IFRS 3 and illustrates the uncertainty and professional judgment involved in asset valuation and consolidation. First, students need to assess the quality of information generated under IFRS 3 and fair value accounting. Second, they are asked to account for a business combination by identifying possible input parameters to measure several intangible assets and a contingent liability. Based on their valuation results, they compute the amount of goodwill recognized on the acquisition and assess the effects of their parameter choices on the values of different assets and liabilities. As an optional third task, the case asks students to consolidate the financial statements and evaluate the impact of the acquisition on the financial position of the acquirer. © 2013 Copyright Taylor and Francis Group, LLC.

AB - This instructional resource familiarizes students with the accounting for business combinations under IFRS 3 and illustrates the uncertainty and professional judgment involved in asset valuation and consolidation. First, students need to assess the quality of information generated under IFRS 3 and fair value accounting. Second, they are asked to account for a business combination by identifying possible input parameters to measure several intangible assets and a contingent liability. Based on their valuation results, they compute the amount of goodwill recognized on the acquisition and assess the effects of their parameter choices on the values of different assets and liabilities. As an optional third task, the case asks students to consolidate the financial statements and evaluate the impact of the acquisition on the financial position of the acquirer. © 2013 Copyright Taylor and Francis Group, LLC.

U2 - 10.1080/09639284.2013.802425

DO - 10.1080/09639284.2013.802425

M3 - Article

VL - 22

SP - 282

EP - 294

JO - Accounting Education: An International Journal

JF - Accounting Education: An International Journal

SN - 0963-9284

IS - 3

ER -